These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

332 related articles for article (PubMed ID: 37026259)

  • 21. Alteration of tear mucin 5AC in office workers using visual display terminals: The Osaka Study.
    Uchino Y; Uchino M; Yokoi N; Dogru M; Kawashima M; Okada N; Inaba T; Tamaki S; Komuro A; Sonomura Y; Kato H; Argüeso P; Kinoshita S; Tsubota K
    JAMA Ophthalmol; 2014 Aug; 132(8):985-92. PubMed ID: 24903353
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Proteases and Their Potential Role as Biomarkers and Drug Targets in Dry Eye Disease and Ocular Surface Dysfunction.
    Ramos-Llorca A; Scarpellini C; Augustyns K
    Int J Mol Sci; 2022 Aug; 23(17):. PubMed ID: 36077189
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Subjective versus objective dry eye disease in patients with moderate-severe thyroid eye disease.
    Kashkouli MB; Alemzadeh SA; Aghaei H; Pakdel F; Abdolalizadeh P; Ghazizadeh M; Moradpasandi F
    Ocul Surf; 2018 Oct; 16(4):458-462. PubMed ID: 30297028
    [TBL] [Abstract][Full Text] [Related]  

  • 24. TFOS DEWS II Sex, Gender, and Hormones Report.
    Sullivan DA; Rocha EM; Aragona P; Clayton JA; Ding J; Golebiowski B; Hampel U; McDermott AM; Schaumberg DA; Srinivasan S; Versura P; Willcox MDP
    Ocul Surf; 2017 Jul; 15(3):284-333. PubMed ID: 28736336
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Association of Dry Eye with Laryngopharyngeal Reflux in Clinical Practice.
    Bonini S; Labetoulle M; Messmer E; Aragona P; Benitez Castillo JM; Ciprandi G; Damiani V; Irkec M; Baudouin C; Rolando M
    Curr Eye Res; 2022 Feb; 47(2):214-219. PubMed ID: 34437824
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rethinking dry eye disease: a perspective on clinical implications.
    Bron AJ; Tomlinson A; Foulks GN; Pepose JS; Baudouin C; Geerling G; Nichols KK; Lemp MA
    Ocul Surf; 2014 Apr; 12(2 Suppl):S1-31. PubMed ID: 24725379
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Rationale for 24-hour management of dry eye disease: A review.
    Guillon M; Shah S
    Cont Lens Anterior Eye; 2019 Apr; 42(2):147-154. PubMed ID: 30497903
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tear Proteomics Approach to Monitoring Sjögren Syndrome or Dry Eye Disease.
    Kuo MT; Fang PC; Chao TL; Chen A; Lai YH; Huang YT; Tseng CY
    Int J Mol Sci; 2019 Apr; 20(8):. PubMed ID: 31010136
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pathological consequences of anti-citrullinated protein antibodies in tear fluid and therapeutic potential of pooled human immune globulin-eye drops in dry eye disease.
    Kwon J; Surenkhuu B; Raju I; Atassi N; Mun J; Chen YF; Sarwar MA; Rosenblatt M; Pradeep A; An S; Dhall N; Mun C; Jain S
    Ocul Surf; 2020 Jan; 18(1):80-97. PubMed ID: 31606460
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The influence of benign essential blepharospasm on dry eye disease and ocular inflammation.
    Lu R; Huang R; Li K; Zhang X; Yang H; Quan Y; Li Q
    Am J Ophthalmol; 2014 Mar; 157(3):591-7.e1-2. PubMed ID: 24269849
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tear Proteomics Study of Dry Eye Disease: Which Eye Do You Adopt as the Representative Eye for the Study?
    Kuo MT; Fang PC; Kuo SF; Chen A; Huang YT
    Int J Mol Sci; 2021 Jan; 22(1):. PubMed ID: 33401599
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Palate Lung Nasal Clone (PLUNC), a Novel Protein of the Tear Film: Three-Dimensional Structure, Immune Activation, and Involvement in Dry Eye Disease (DED).
    Schicht M; Rausch F; Beron M; Jacobi C; Garreis F; Hartjen N; Beileke S; Kruse F; Bräuer L; Paulsen F
    Invest Ophthalmol Vis Sci; 2015 Nov; 56(12):7312-23. PubMed ID: 26559477
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differentiating primary dry eye disease from ocular neuropathic pain: implications for symptom management.
    Forristal MT; Stephenson KAJ
    Clin Exp Optom; 2023 Aug; 106(6):605-611. PubMed ID: 36004515
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Varenicline Solution Nasal Spray: A Review in Dry Eye Disease.
    Frampton JE
    Drugs; 2022 Sep; 82(14):1481-1488. PubMed ID: 36197638
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dry Eye Disease: What Is the Role of Vitamin D?
    Rolando M; Barabino S
    Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36674972
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Management Strategies for Evaporative Dry Eye Disease and Future Perspective.
    Rolando M; Merayo-Lloves J
    Curr Eye Res; 2022 Jun; 47(6):813-823. PubMed ID: 35521685
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Contribution of break up time in the diagnosis and the treatment of dry eye syndrome in tropic area: about 234 patients in Abidjan].
    Ouffoue GY; Boni S; Ouattara AO; Gbe K; Kouassi LJK; Konan AJ; Gombe E; Ouonnebo L; Agbohoun RP; Fanny A; Cheucheu WJ
    J Fr Ophtalmol; 2019 Sep; 42(7):716-721. PubMed ID: 31133400
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A Comprehensive Review of the Clinical Trials Conducted for Dry Eye Disease and the Impact of the Vehicle Comparators in These Trials.
    Nichols KK; Evans DG; Karpecki PM
    Curr Eye Res; 2021 May; 46(5):609-614. PubMed ID: 33238774
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Severity of clinical dry eye manifestations influences protein expression in tear fluid of patients with primary Sjögren's syndrome.
    Aqrawi LA; Chen X; Jensen JL; Morthen MK; Thiede B; Utheim ØA; Palm Ø; Tashbayev B; Utheim TP; Galtung HK
    PLoS One; 2018; 13(10):e0205762. PubMed ID: 30312344
    [TBL] [Abstract][Full Text] [Related]  

  • 40. NLRP3 Inflammasome as a Potential Therapeutic Target in Dry Eye Disease.
    Zhuang D; Misra SL; Mugisho OO; Rupenthal ID; Craig JP
    Int J Mol Sci; 2023 Jun; 24(13):. PubMed ID: 37446038
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.